Nigam P K
Dept. of Cardiology, King George's Medical University, 226 003 Lucknow.
Indian J Clin Biochem. 2007 Mar;22(1):10-7. doi: 10.1007/BF02912874.
The serum markers of myocardial injury are used to help in establishing the diagnosis of myocardial infarction. The older markers like aspartate amino-transferase, creatine kinase, lactate dehydrogenase etc. lost their utility due to lack of specificity and limited sensitivities. Among the currently available markers cardiac troponins are the most widely used due to their improved sensitivity specificity, efficiency and low turn around time. Studies have shown that cardiac troponins should replace CKMB as the diagnostic 'gold standard' for the diagnosis of myocardial injury. The combination of myoglobin with cardiac troponins has further improved the accuracy in the diagnosis of acute coronary syndromes and thereby reducing the hospital stay and patients' money. Among the other new markers of early detection of myocardial damage, heart fatty acid binding protein, glycogen phosphorylase BB and myoglobin/carbonic anhydrase III ratio seem to be the most promising. But the search for the most ideal marker of myocardial injury is still on.
心肌损伤的血清标志物用于辅助心肌梗死的诊断。像天冬氨酸转氨酶、肌酸激酶、乳酸脱氢酶等较老的标志物,由于缺乏特异性和敏感性有限而失去了效用。在目前可用的标志物中,心肌肌钙蛋白因其更高的敏感性、特异性、效率和较短的周转时间而被最广泛使用。研究表明,心肌肌钙蛋白应取代肌酸激酶同工酶(CKMB)作为心肌损伤诊断的“金标准”。肌红蛋白与心肌肌钙蛋白的联合使用进一步提高了急性冠状动脉综合征的诊断准确性,从而缩短了住院时间并降低了患者费用。在其他早期检测心肌损伤的新标志物中,心脏脂肪酸结合蛋白、糖原磷酸化酶BB和肌红蛋白/碳酸酐酶III比值似乎最具前景。但对最理想的心肌损伤标志物的探索仍在继续。